Creation of the Biobank Related to Eye Disease
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 669
- 试验地点
- 1
- 主要终点
- To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies
研究概览
简要总结
The purpose of this study is to develop a BioBank (a specialized lab) and collect blood, fluids and/or other tissue samples to study eye diseases.
详细描述
The purpose of the Biobank related to eye disease at Beaumont Hospital is to help connect specialties and Specialists with each other, outside traditional limits of hospital or laboratory departments. The specimens (blood, fluids, and/or tissue samples) that will be collected from men, women and children will assist the researchers in a variety of studies on human eye diseases.
Research utilizing these specimens will allow for an increased understanding of the etiology, disease process, and response to treatments for various eye diseases, and will provide opportunities to subsequently improve our management decisions. Furthermore, projects that cross over between subspecialties are sparse and that is a limiting factor for the development of research that takes a more comprehensive approach.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All pediatric and adult patients age 0-99 years -
排除标准
- •All patients who do not agree to consent for collection of blood, fluids, tissue.
- •Patients who are cognitively impaired and are not able to verbalize understanding of the risks/benefits.
结局指标
主要结局
To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies
Biobanks can be used for numberous discovery applications such as: identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization and validation of biomarkers that are predictive of disease and treatment.
次要结局
未报告次要终点
研究者
Kimberly Drenser
M.D, Ph.D.
William Beaumont Hospitals
